Condensed Consolidated Statements of Earnings (Unaudited) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Mar. 31, 2026	Mar. 31, 2025
Income Statement [Abstract]
Net sales	$ 1,670	$ 1,668	$ 4,772	$ 5,116
Cost of products sold	948	924	2,732	2,827
Gross profit	722	744	2,040	2,289
Selling and administrative expenses	229	267	768	828
Advertising costs	177	207	533	599
Research and development costs	27	27	84	89
Loss on divestiture	0	0	0	118
Interest expense	27	23	75	66
Other (income) expense, net	6	(34)	2	(79)
Earnings before income taxes	256	254	578	668
Income tax expense	65	63	144	180
Net earnings	191	191	434	488
Less: Net earnings attributable to noncontrolling interests	4	5	10	10
Net earnings attributable to Clorox	$ 187	$ 186	$ 424	$ 478
Net earnings per share attributable to Clorox
Basic net earnings per share (in dollars per share)	$ 1.54	$ 1.51	$ 3.48	$ 3.87
Diluted net earnings per share (in dollars per share)	$ 1.54	$ 1.50	$ 3.47	$ 3.84
Weighted average shares outstanding (in thousands)
Basic (in shares)	121,363	123,367	121,865	123,643
Diluted (in shares)	121,787	124,066	122,240	124,468